Optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with modified FOLFOX6: a randomized pilot study.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);止吐药(Antiemetics);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);结直肠肿瘤(Colorectal Neoplasms);用药计划表(Drug Administration Schedule);可行性研究(Feasibility Studies);女(雌)性(Female);氟尿嘧啶(Fluorouracil);人类(Humans);醛氢叶酸(Leucovorin);男(雄)性(Male);中年人(Middle Aged);恶心(Nausea);有机铂化合物(Organoplatinum Compounds);试点项目(Pilot Projects);吡唑类(Pyrazoles);血清素5-HT3受体拮抗剂(Serotonin 5-HT3 Receptor Antagonists);血清素5-HT4受体拮抗剂(Serotonin 5-HT4 Receptor Antagonists);治疗结果(Treatment Outcome);呕吐(Vomiting)
DOI
10.1159/000345920
PMID
23364217
发布时间
2016-11-25
- 浏览4

Chemotherapy
439-44页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文